Evidence method
Level · gp.fundamentals.debt_to_revenue
152.75% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
HBIO · Sep 30, 2023
HARVARD BIOSCIENCE INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001171843-23-006831General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.86% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.19% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-5.79% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
101.79% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
58.06% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-3.68% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.88% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5.37% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20230/9 normalizedLevel 3Mar 31, 20240/9 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20248/9 normalizedLevel 3Dec 31, 20248/9 normalizedLevel 3Mar 31, 20258/9 normalizedLevel 3Jun 30, 20258/9 normalizedLevel 3Sep 30, 20259/9 normalizedLevel 3Dec 31, 20259/9 normalizedLevel 3Mar 31, 20269/9 normalizedLevel 3Jun 30, 20269/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 144.03%
- Current
- 152.75%
- Delta
- 8.72%
- Previous
- 1.80%
- Current
- 0.86%
- Delta
- -0.94%
- Previous
- 12.35%
- Current
- 17.19%
- Delta
- 4.84%
- Previous
- 90.72%
- Current
- 101.79%
- Delta
- 11.08%
- Previous
- 57.97%
- Current
- 58.06%
- Delta
- 0.09%
- Previous
- 2.77%
- Current
- -3.68%
- Delta
- -6.45%
- Previous
- 10.28%
- Current
- 10.88%
- Delta
- 0.60%
- Previous
- 3.83%
- Current
- 5.37%
- Delta
- 1.54%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · HBIO Fundamental State →Has State · HARVARD BIOSCIENCE INC →Transitioned To · HBIO Fundamental State →Transitioned To · HBIO BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · HBIO CAPEX_INTENSITY_DECREASED →Transitioned To · HBIO CASH_GENERATION_INCREASED →Transitioned To · HBIO INVENTORY_PRESSURE_INCREASED →Transitioned To · HBIO MARGIN_INCREASED →Transitioned To · HBIO PROFITABILITY_DECREASED →Transitioned To · HBIO R_AND_D_INTENSITY_INCREASED →Transitioned To · HBIO SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.